In the liver, Ppara enhances lipid metabolism and is generally considered to have an inhibitory effect on hepatic steatosis, although some reports suggest that Ppara may promote the pathogenesis of non-alcoholic steatohepatitis [75, 76]. This evidence concerns the gene PPARA and fatty liver disease.